Drug manufacturer Boehringer Ingelheim (BI) sued the federal government this afternoon in federal district court in Washington, D.C., in defense of its policy of denying hospitals 340B drug discounts when hospitals use contract pharmacies.
BI is the seventh manufacturer to file such a suit in defense of such a policy. The others are Astra Zeneca, Lilly, Novartis, Novo Nordisk, Sanofi, and United Therapeutics. An eighth manufacturer, Merck, on Sept. 1 began denying 340B discounts to hospitals that use contract pharmacies if the hospitals decline to provide their 340B contract pharmacy claims data. That policy also is eventually expected to lead to an eighth lawsuit by a drug manufacturer this year.
Drug manufacturer Boehringer Ingelheim (BI) sued the federal government this afternoon in federal district court in Washington, D.C., in defense of its policy of denying hospitals 340B drug discounts when hospitals use contract pharmacies.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
